Exploration on the dose-effect relationship of ropivacaine ultrasound-guided supra-inguinal fascia iliaca compartment block for postoperative analgesia of total hip arthroplasty.

Exploration on the dose-effect relationship of ropivacaine ultrasound-guided supra inguinal fascia iliaca compartment block for postoperative analgesia of total hip arthroplasty

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400092413

Enrollment

Unknown

Registered

2024-11-15

Start date

2024-11-15

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total hip arthroplasty

Interventions

Experimental group:Various concentrations of ropivacaine with 30mL volume for ultrasound-guided supra-inguinal fascia iliaca compartment block

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18-80 years. 2. ASA grade I - III. 3.Patients who underwent the first Total hip arthroplasty, join the research voluntary and obtained informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with BIM=35; 2. Allergic to related drugs; 3. Inability to cooperate with pain evaluators; 4. Severe heart, lung, liver and kidney disease; 5. Diabetic peripheral neuropathy; 6. Patients with chronic pain treatment; 7.Alcohol or drug addicts; 8. Persons with serious mental illness; 9. Pregnant women; 10.Patients with contraindications to nerve block puncture.

Design outcomes

Primary

Measure	Time frame
Score of visual analogue scale ;	—

Secondary

Measure	Time frame
Press times of PCIA;Score of Bromage;Success rate of S-FICB;Remifentanil dosage;PCIA dosage;Percentage of patients requiring tramadol supplementation within 6 hours;	—

Countries

China

Contacts

Public ContactYanping Zhang

Chongqing Traditional Chinese Medicine Hospital

zhangyp8415@163.com+86 152 2304 9366

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026